Ingevity Balans Gezondheid
Financiële gezondheid criteriumcontroles 1/6
Ingevity heeft een totaal eigen vermogen van $214.5M en een totale schuld van $1.4B, wat de schuld-eigenvermogensverhouding op 652.5% brengt. De totale activa en totale passiva bedragen respectievelijk $2.2B en $2.0B. De EBIT Ingevity is $233.1M waardoor de rentedekking 2.6 is. Het heeft contanten en kortetermijnbeleggingen van $135.5M.
Belangrijke informatie
652.5%
Verhouding schuld/eigen vermogen
US$1.40b
Schuld
| Rente dekkingsratio | 2.6x |
| Contant | US$135.50m |
| Aandelen | US$214.50m |
| Totaal verplichtingen | US$2.00b |
| Totaal activa | US$2.21b |
Recente financiële gezondheidsupdates
Is Ingevity (NYSE:NGVT) A Risky Investment?
Oct 13
Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky
Jul 13Is Ingevity (NYSE:NGVT) A Risky Investment?
Mar 22Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt
Sep 22Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt
Jun 21We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt
Feb 16Recent updates
Is Ingevity (NYSE:NGVT) A Risky Investment?
Oct 13Ingevity Corporation's (NYSE:NGVT) Prospects Need A Boost To Lift Shares
Sep 08Ingevity: The Risk-Reward Ratio Is Still Unfavorable
Aug 27Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 03Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky
Jul 13Should You Investigate Ingevity Corporation (NYSE:NGVT) At US$45.90?
Jun 14Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?
Apr 18Is Ingevity (NYSE:NGVT) A Risky Investment?
Mar 22What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?
Jan 23Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares
Jan 04These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts
Nov 10Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?
Oct 07Ingevity Corporation: The Risk To Reward Is Currently Favorable
Oct 06Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt
Sep 22Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?
Aug 11Ingevity Corporation: Headwinds Are Temporary
Jul 05Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt
Jun 21Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?
May 29We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt
Feb 16Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?
Jan 25Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate
Sep 13Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?
Aug 22Ingevity to acquire pavement marking materials business Ozark Materials for $325M
Aug 02Ingevity (NYSE:NGVT) Seems To Use Debt Quite Sensibly
Aug 01Ingevity (NYSE:NGVT) Will Want To Turn Around Its Return Trends
Jun 05What Does Ingevity Corporation's (NYSE:NGVT) Share Price Indicate?
May 20Ingevity: Well-Diversified ESG Chemicals Company To Put On Watchlist
May 03We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt
May 02Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $636.8M ) NGVT } overtreffen de korte termijn passiva ( $360.8M ).
Langlopende schulden: De kortetermijnactiva van NGVT ( $636.8M ) dekken de langetermijnschulden ( $1.6B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 589.4% ) NGVT wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van NGVT is de afgelopen 5 jaar gestegen van 280.2% naar 652.5%.
Schuldendekking: De schuld van NGVT wordt niet goed gedekt door de operationele kasstroom ( 7.9% ).
Rentedekking: De rentebetalingen van NGVT op haar schulden worden niet goed gedekt door EBIT ( 2.6 x dekking).